Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Aug;32(4):229-43.
doi: 10.1007/s11017-011-9179-8.

The placebo phenomenon and medical ethics: rethinking the relationship between informed consent and risk-benefit assessment

Affiliations

The placebo phenomenon and medical ethics: rethinking the relationship between informed consent and risk-benefit assessment

Franklin G Miller et al. Theor Med Bioeth. 2011 Aug.

Abstract

It has been presumed within bioethics that the benefits and risks of treatments can be assessed independently of information disclosure to patients as part of the informed consent process. Research on placebo and nocebo effects indicates that this is not true for symptomatic treatments. The benefits and risks that patients experience from symptomatic treatments can be shaped powerfully by information about these treatments provided by clinicians. In this paper we discuss the implications of placebo and nocebo research for risk-benefit assessment and informed consent.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Lancet. 2010 Sep 25;376(9746):1085-92 - PubMed
    1. Perspect Biol Med. 2009 Autumn;52(4):518-39 - PubMed
    1. Pain. 1997 Aug;72(1-2):107-13 - PubMed
    1. Lancet Neurol. 2004 Nov;3(11):679-84 - PubMed
    1. Ann Intern Med. 1982 Jul;97(1):112-8 - PubMed

Publication types

LinkOut - more resources